Analyzing the causal relationship between gut microbiotas, blood metabolites, and COVID-19 susceptibility: A Mendelian randomization study
Open Access
- 4 April 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (14) , e41445
Abstract
Gut microbiota and blood metabolites play crucial roles in the progression and outcomes of COVID-19, but the causal relationships and mechanisms remain unclear. Our aim is to use two-sample Mendelian randomization (MR) to explore the causal relationships between gut microbiota, COVID-19 susceptibility, and potential mediating blood metabolites. We utilized summary statistics from the largest genome-wide association studies (GWAS) to date on gut microbiota (n = 18,340), blood metabolites (n = 115,078), and COVID-19 susceptibility (cases n = 60,176 and controls n = 1310,725 from the COVID-19 Host Genetics Initiative meta-analysis). We conducted bidirectional MR analyses to explore the causal relationships between gut microbiota and COVID-19 susceptibility and performed two-step MR to identify potential mediating blood metabolites. Five analytical methods were used to assess two-sample causal relationships, with inverse variance weighted (IVW) being the primary method. Sensitivity analyses were also conducted to ensure the robustness of the main MR results. Using the IVW method, we found causal relationships between 3 types of gut microbiota and 34 blood metabolites with COVID-19 susceptibility. In the two-step MR, the non-oxidative branch of the Pentose phosphate pathway was shown to reduce Sebacate (C10-DC) levels, and the species Parabacteroides goldsteinii was negatively correlated with Acetoacetate levels. Sebacate (C10-DC) levels were negatively associated with COVID-19 susceptibility, while Acetoacetate levels were positively associated with COVID-19 susceptibility. Furthermore, these causal relationships remained significant after correcting for false discovery rates (all q-values < 0.05). Heterogeneity and pleiotropy tests showed no statistical significance (P > .05). Mediation analysis indicated that the abundance of the non-oxidative branch of the Pentose phosphate pathway and COVID-19 susceptibility was mediated by Sebacate (C10-DC) levels (mediation proportion of 15.8%), and the abundance of P goldsteinii and COVID-19 susceptibility was mediated by Acetoacetate levels (mediation proportion of 31.7%). The current MR study provides evidence supporting the causal relationships between several specific gut microbiotas and COVID-19 susceptibility, as well as potential mediating blood metabolites. Our findings warrant further validation through larger epidemiological studies.Keywords
This publication has 43 references indexed in Scilit:
- Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 PathogenesisCell Metabolism, 2020
- COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorptionEating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2020
- The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemicEuropean Journal of Human Genetics, 2020
- Meta‐analysis andMendelianrandomization: A reviewResearch Synthesis Methods, 2019
- Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseasesNature Genetics, 2019
- Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensisGut, 2018
- Genome-Wide Association Studies2018
- Effect of decanoic acid and 10-hydroxydecanoic acid on the biotransformation of methyl decanoate to sebacic acidAMB Express, 2018
- Use of dicarboxylic acids in type 2 diabetesBritish Journal of Clinical Pharmacology, 2012
- Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolitesProceedings of the National Academy of Sciences of the United States of America, 2009